The promise of paediatric dolutegravir

J Int AIDS Soc. 2021 Jan;24(1):e25660. doi: 10.1002/jia2.25660.
No abstract available

Keywords: HIV; antiretroviral therapy; children; dolutegravir; paediatric.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Child
  • HIV Infections / drug therapy*
  • HIV Integrase Inhibitors / economics
  • HIV Integrase Inhibitors / therapeutic use*
  • Heterocyclic Compounds, 3-Ring / economics
  • Heterocyclic Compounds, 3-Ring / therapeutic use*
  • Humans
  • Oxazines / economics
  • Oxazines / therapeutic use*
  • Piperazines / economics
  • Piperazines / therapeutic use*
  • Pyridones / economics
  • Pyridones / therapeutic use*

Substances

  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir